Cleave Selected Press Releases Archive
<<< Back to Newsroom

Year

Press Release
2016 Cleave Biosciences Raises $37 Million Series B Financing
2015 Cleave Biosciences Granted Key U.S. Patent Covering CB-5083
Cleave Biosciences Receives Orphan Designation from FDA for CB-5083 for Treatment of Multiple Myeloma
2014 Cleave Biosciences Initiates Phase 1 Clinical Trial of CB-5083 in Patients with Multiple Myeloma
Cleave Biosciences Initiates Phase 1 Clinical Trial of CB-5083 in Patients with Advanced Solid Tumors
2013 Cleave Biosciences Adds New Investor and $10 Million to Series A Financing
2011 Cleave Biosciences Raises Additional $2 Million in Series A Financing
Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies